Press releases
- Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
- Immunovia publishes the annual report for 2023
- Immunovia Publishes Interim Report for January-March 2024
- Invitation to Immunovia's Q1 presentation
- Immunovia announces updated financial calendar
- Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
- Immunovia Publishes Full Year Report for 2023
- Invitation to Immunovia's Q4 presentation
More ▼
Key statistics
As of last trade, Immunovia AB (publ) (1YR:FRA) traded at 0.1544, 154,300.00% above the 52 week low of 0.0001 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1544 |
---|---|
High | 0.1544 |
Low | 0.1544 |
Bid | 0.1518 |
Offer | 0.2035 |
Previous close | 0.1526 |
Average volume | 0.00 |
---|---|
Shares outstanding | 45.29m |
Free float | 34.20m |
P/E (TTM) | -- |
Market cap | 92.77m SEK |
EPS (TTM) | -6.06 SEK |
Data delayed at least 15 minutes, as of May 02 2024 08:17 BST.
More ▼